• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Zepp Health Corporation (Amendment)

    2/9/23 7:57:21 AM ET
    $ZEPP
    Computer Manufacturing
    Technology
    Get the next $ZEPP alert in real time by email
    SC 13G/A 1 filing.txt SCHEDULE 13G Amendment No. 3 ZEPP HEALTH CORP CLASS A COMMON STOCK Cusip #98945L105 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [x] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) Cusip #98945L105 Item 1: Reporting Person - FIL Limited Item 2: (a) [ ] (b) [ ] Item 4: Bermuda Item 5: 11,321,308 Item 6: 0 Item 7: 13,084,692 Item 8: 0 Item 9: 13,084,692 Item 11: 9.926% Item 12: FI Cusip #98945L105 Item 1: Reporting Person - Pandanus Partners, L.P. Item 2: (a) [ ] (b) [ ] Item 4: Delaware Item 5: 0 Item 6: 0 Item 7: 13,084,692 Item 8: 0 Item 9: 13,084,692 Item 11: 9.926% Item 12: PN Cusip #98945L105 Item 1: Reporting Person - Pandanus Associates, Inc. Item 2: (a) [ ] (b) [ ] Item 4: Delaware Item 5: 0 Item 6: 0 Item 7: 13,084,692 Item 8: 0 Item 9: 13,084,692 Item 11: 9.926% Item 12: CO Item 1(a). Name of Issuer: ZEPP HEALTH CORP Item 1(b). Address of Issuer's Principal Executive Offices: BUILDING B2, ZHONG'AN CHUANGGU, TECHNOLOGY PARK NO.900 WANGJIANG WEST RD HEFEI, F4 230088 CHINA Item 2(a). Name of Person Filing: FIL Limited Item 2(b). Address or Principal Business Office or, if None, Residence: Pembroke Hall, 42 Crow Lane, Hamilton, Bermuda, HM19 Item 2(c). Citizenship: Not applicable Item 2(d). Title of Class of Securities: CLASS A COMMON STOCK Item 2(e). CUSIP Number: 98945L105 Item 3. This statement is filed pursuant to Rule 13d-1(b) or 13d-2(b) or (c) and the person filing, FIL Limited, is a non-U.S. institution in accordance with Section 240.13d-1(b)(1)(ii)(J). (Note: See Exhibit A). If filing as a non-U.S. institution in accordance with Section 240.13d-1(b)(1)(ii)(J), please specify type of institution: Parent holding or control person. Item 4. Ownership (a) Amount Beneficially Owned: 13,084,692 (b) Percent of Class: 9.926% (c) Number of shares as to which such person has: (i) sole power to vote or to direct the vote: 11,321,308 (ii) shared power to vote or to direct the vote: 0 (iii) sole power to dispose or to direct the disposition of: 13,084,692 (iv) shared power to dispose or to direct the disposition of: 0 Item 5. Ownership of Five Percent or Less of a Class. Not applicable. Item 6. Ownership of More than Five Percent on Behalf of Another Person. One or more other persons are known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the CLASS A COMMON STOCK of ZEPP HEALTH CORP. The interest of Fidelity China Special Situations PLC, in the CLASS A COMMON STOCK of ZEPP HEALTH CORP, amounted to 7,992,332 shares or 6.063% of the total outstanding CLASS A COMMON STOCK at December 30, 2022. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company. See attached Exhibit A. Item 8. Identification and Classification of Members of the Group. Not applicable. Item 9. Notice of Dissolution of Group. Not applicable. Item 10. Certifications. By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. By signing below I certify that, to the best of my knowledge and belief, the foreign regulatory scheme applicable to FIL Limited and its various non-U.S. investment management subsidiaries included on this Schedule 13G is substantially comparable to the regulatory scheme applicable to the functionally equivalent U.S. institutions. I also undertake to furnish to the Commission staff, upon request, information that would otherwise be disclosed in a Schedule 13D. Signature After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. February 9, 2023 Date /s/ Stephanie J. Brown Signature Stephanie J. Brown Duly authorized under Power of Attorney effective as of December 19, 2022, by and on behalf of FIL Limited and its direct and indirect subsidiaries* * This power of attorney is incorporated herein by reference to Exhibit 24 to the Schedule 13G filed by FIL Limited on January 31, 2023, accession number: 0000318989-23-000005. Exhibit A Pursuant to the instructions in Item 7 of Schedule 13G, the following table lists the identity and Item 3 classification, if applicable, of each relevant entity that beneficially owns shares of the security class being reported on this Schedule 13G. Entity ITEM 3 Classification FIL Investment Management (Hong Kong) Limited FI FIL Investment Services (UK) Limited * FI FIL Investments International FI * Entity beneficially owns 5% or greater of the outstanding shares of the security class being reported on this Schedule 13G. Pandanus Partners, L.P. ("Pandanus") owns shares of FIL Limited ("FIL") voting stock. While the percentage of total voting power represented by these shares of FIL voting stock may fluctuate as a result of changes in the total number of shares of FIL voting stock outstanding from time to time, it normally represents more than 25% and less than 48.5% of the total votes which may be cast by all holders of FIL voting stock. Pandanus Associates, Inc. ("PAI") acts as general partner of Pandanus. Pandanus is owned by trusts for the benefit of members of the Johnson family, including FIL's Chairman Abigail P. Johnson, but disclaims that any such member is a beneficial owner of the securities reported on this Schedule 13G. This filing reflects the securities beneficially owned, or that may be deemed to be beneficially owned, by FIL, certain of its subsidiaries and affiliates, and other companies (collectively, the "FIL Reporters"). This filing does not reflect securities, if any, beneficially owned by certain other companies whose beneficial ownership of securities is disaggregated from that of the FIL Reporters in accordance with Securities and Exchange Commission Release No. 34-39538 (January 12, 1998). RULE 13d-1(k)(1) AGREEMENT The undersigned persons, on February 9, 2023, agree and consent to the joint filing on their behalf of this Schedule 13G in connection with their beneficial ownership of the CLASS A COMMON STOCK of ZEPP HEALTH CORP at December 30, 2022. FIL Limited By /s/ Stephanie J. Brown Stephanie J. Brown Duly authorized under Power of Attorney effective as of December 19, 2022, by and on behalf of FIL Limited and its direct and indirect subsidiaries* Pandanus Partners, L.P. By /s/ Stephanie J. Brown Stephanie J. Brown Duly authorized under Power of Attorney effective as of December 19, 2022, by Pandanus Associates, Inc. on behalf of Pandanus Partners, L.P.* Pandanus Associates, Inc. By /s/ Stephanie J. Brown Stephanie J. Brown Duly authorized under Power of Attorney effective as of December 19, 2022, by and on behalf of Pandanus Associates, Inc.* * This power of attorney is incorporated herein by reference to Exhibit 24 to the Schedule 13G filed by FIL Limited on January 31, 2023, accession number: 0000318989-23-000005.
    Get the next $ZEPP alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $ZEPP

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $ZEPP
    Financials

    Live finance-specific insights

    See more
    • Zepp Health Corporation Reports First Quarter 2025 Unaudited Financial Results

      MILPITAS, Calif., May 19, 2025 /PRNewswire/ -- Zepp Health Corporation ("Zepp" or the "Company") (NYSE:ZEPP) today announced its unaudited financial results for the first quarter of 2025. First Quarter 2025 Financial and Operating Highlights: Revenue reached US$39 million, out of which Amazfit-branded products grew by 10.2% year-over-year.Gross margin was 37.3% compared with 36.8% in the same period of last yearCash balance was 104 million, after repayment of US$11.5 million short-term debt in the first quarter of 2025.The U.S.-China reached deal to temporarily reduce tariffs; the company has proactively established a dual-sourcing supply chain strategy with production bases in both China a

      5/19/25 8:40:00 PM ET
      $ZEPP
      Computer Manufacturing
      Technology
    • Zepp Health Corporation to Report First Quarter 2025 Financial Results on May 19, 2025

      Earnings Call Scheduled for 9:00 p.m. ET on May 19, 2025 MILPITAS, Calif., May 7, 2025 /PRNewswire/ -- Zepp Health Corporation ("Zepp Health" or the "Company") (NYSE:ZEPP), a global leader in smart wearables and health technology, today announced that it will report its first quarter 2025 unaudited financial results after the market close on Monday, May 19, 2025. Management will hold a conference call at 9:00 p.m. Eastern Time on Monday, May 19, 2025. Listeners may access the call by dialing: US (Toll Free): +1-888-346-8982 International: +1-412-902-4272 Mainland China (Toll Free): 400-120-1203 Hong Kong (Toll Free): 800-905-945 Hong Kong: +852-3018-4992 Participants should dial in at leas

      5/7/25 8:00:00 AM ET
      $ZEPP
      Computer Manufacturing
      Technology
    • Zepp Health Corporation Reports Fourth Quarter and Full Year 2024 Unaudited Financial Results

      MILPITAS, Calif., March 26, 2025 /PRNewswire/ -- Zepp Health Corporation ("Zepp" or the "Company") (NYSE:ZEPP) today announced its unaudited financial results for the fourth quarter of 2024. Fourth Quarter 2024 Financial and Operating Highlights: Revenue reached US$59.5 million representing a 40.2% of quarter over quarter increase, out of which our Amazfit-branded products grew by 43.4% quarter-over-quarter.Gross margin was 36.8% compared with 34.7% in the same period last year.Adjusted operating loss[1] was US$7.4 million, which was the lowest level in 2024.Full Year 2024 Financial and Operating Highlights: Gross margin was 38.5% compared with 26.2% in the full year of 2023.Adjusted operat

      3/26/25 5:00:00 PM ET
      $ZEPP
      Computer Manufacturing
      Technology

    $ZEPP
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Zepp Health Corporation Reports First Quarter 2025 Unaudited Financial Results

      MILPITAS, Calif., May 19, 2025 /PRNewswire/ -- Zepp Health Corporation ("Zepp" or the "Company") (NYSE:ZEPP) today announced its unaudited financial results for the first quarter of 2025. First Quarter 2025 Financial and Operating Highlights: Revenue reached US$39 million, out of which Amazfit-branded products grew by 10.2% year-over-year.Gross margin was 37.3% compared with 36.8% in the same period of last yearCash balance was 104 million, after repayment of US$11.5 million short-term debt in the first quarter of 2025.The U.S.-China reached deal to temporarily reduce tariffs; the company has proactively established a dual-sourcing supply chain strategy with production bases in both China a

      5/19/25 8:40:00 PM ET
      $ZEPP
      Computer Manufacturing
      Technology
    • Zepp Health Corporation to Report First Quarter 2025 Financial Results on May 19, 2025

      Earnings Call Scheduled for 9:00 p.m. ET on May 19, 2025 MILPITAS, Calif., May 7, 2025 /PRNewswire/ -- Zepp Health Corporation ("Zepp Health" or the "Company") (NYSE:ZEPP), a global leader in smart wearables and health technology, today announced that it will report its first quarter 2025 unaudited financial results after the market close on Monday, May 19, 2025. Management will hold a conference call at 9:00 p.m. Eastern Time on Monday, May 19, 2025. Listeners may access the call by dialing: US (Toll Free): +1-888-346-8982 International: +1-412-902-4272 Mainland China (Toll Free): 400-120-1203 Hong Kong (Toll Free): 800-905-945 Hong Kong: +852-3018-4992 Participants should dial in at leas

      5/7/25 8:00:00 AM ET
      $ZEPP
      Computer Manufacturing
      Technology
    • Zepp Health Corporation Files 2024 Annual Report on Form 20-F

      MILPITAS, Calif., April 25, 2025 /PRNewswire/ -- Zepp Health Corporation ("Zepp Health" or the "Company") (NYSE:ZEPP), a global leader in smart wearables and health technology, today announced that it has filed its annual report on Form 20-F for the full year ended December 31, 2024 with the U.S. Securities and Exchange Commission (the "SEC"). The annual report can be accessed on the Company's investor relations website at http://ir.zepp.com and on the SEC's website at www.sec.gov. The Company will provide hardcopies of the annual report, free of charge, to its shareholders and ADS holders upon request. Requests should be submitted to [email protected]. About Zepp Health Corporation (NYSE:ZEPP) Z

      4/25/25 5:00:00 PM ET
      $ZEPP
      Computer Manufacturing
      Technology

    $ZEPP
    Leadership Updates

    Live Leadership Updates

    See more
    • Italian Tennis Star Jasmine Paolini Joins Amazfit as Latest Athlete Ambassador

      Paolini to Wear Amazfit Smart Wearables to Enhance Performance and Recovery. Amazfit logo to appear on Paolini's on-court apparel. Amazfit, a leading global smart wearables brand owned by Zepp Health (NYSE:ZEPP), today announced the signing of Italian tennis sensation and World No. 4 Jasmine Paolini as its newest global athlete partner. As part of the multi-year agreement and official smart wearable partnership, Paolini will represent Amazfit by wearing the Amazfit logo and smartwatch on court and the brand's fitness wearables, including Helio Ring, to track sleep and athletic recovery. This press release features multimedia. View the full release here: https://www.businesswire.com/news/h

      2/18/25 10:00:00 AM ET
      $ZEPP
      Computer Manufacturing
      Technology
    • Five-Time Olympic Medalist Gabby Thomas Joins Amazfit as Athlete Ambassador

      Amazfit becomes Thomas' first Smartwatch Partner Amazfit, a leading global smart wearables brand owned by Zepp Health (NYSE:ZEPP), is proud to announce five-time Olympic Medalist and fashion icon, Gabby Thomas, as the latest ambassador to join the brand's growing roster of elite athletes. As part of the four-year partnership, Thomas will wear Amazfit smartwatches both on the track during training and in competition, and off the track to monitor sleep and recovery. Moreover, through the Zepp app-based food log, Gabby will have easy access to nutrition-tracking as well. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250213824479

      2/13/25 12:00:00 PM ET
      $ZEPP
      Computer Manufacturing
      Technology

    $ZEPP
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Zepp Health Corporation

      SC 13G/A - Zepp Health Corp (0001720446) (Subject)

      11/12/24 6:19:43 AM ET
      $ZEPP
      Computer Manufacturing
      Technology
    • Amendment: SEC Form SC 13G/A filed by Zepp Health Corporation

      SC 13G/A - Zepp Health Corp (0001720446) (Subject)

      10/4/24 8:26:45 AM ET
      $ZEPP
      Computer Manufacturing
      Technology
    • Amendment: SEC Form SC 13G/A filed by Zepp Health Corporation

      SC 13G/A - Zepp Health Corp (0001720446) (Subject)

      10/4/24 8:24:55 AM ET
      $ZEPP
      Computer Manufacturing
      Technology

    $ZEPP
    SEC Filings

    See more
    • Amendment: SEC Form 20-F/A filed by Zepp Health Corporation

      20-F/A - Zepp Health Corp (0001720446) (Filer)

      5/21/25 8:07:07 AM ET
      $ZEPP
      Computer Manufacturing
      Technology
    • SEC Form 6-K filed by Zepp Health Corporation

      6-K - Zepp Health Corp (0001720446) (Filer)

      5/20/25 6:05:58 AM ET
      $ZEPP
      Computer Manufacturing
      Technology
    • Amendment: SEC Form SCHEDULE 13G/A filed by Zepp Health Corporation

      SCHEDULE 13G/A - Zepp Health Corp (0001720446) (Subject)

      5/7/25 11:05:28 AM ET
      $ZEPP
      Computer Manufacturing
      Technology